Overview

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-01-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of VYN201 Gel in subjects with non-segmental vitiligo.

Phase:

PHASE2

Details

Lead Sponsor:

Vyne Therapeutics Inc.